AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Aviglic MF 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Avinash Health Products Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Aviglic MF 80mg/500mg Tablet

Diabex Duo 80 mg/500 mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation helps regulate blood glucose in diabetic patients. Diabex Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical advice can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation, and vomiting. Prompt glucose intake (sugary foods or juice) is essential to manage hypoglycemia. Regular meals and carrying a fast-acting glucose source are recommended. Alcohol consumption should be minimized due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Its suitability for pregnant or breastfeeding women requires medical consultation. Regular blood glucose monitoring and potential blood tests (blood cell counts and liver function) will be advised by your doctor.

Uses of Aviglic MF 80mg/500mg Tablet

Diabetes mellitus type 2

Major Benefits of Aviglic MF 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Aviglic MF 80 mg/500 mg tablets should be administered with a meal.

Common Side effects of Aviglic MF 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Aviglic MF 80mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 80 mg/500 mg Aviglic MF tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Aviglic MF 80mg/500mg Tablet works:

Each Aviglic MF 80 mg/500 mg tablet combines the antidiabetic agents gliclazide and metformin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Aviglic MF 80 mg/500 mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Aviglic MF 80 mg/500 mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Aviglic MF 80 mg/500 mg tablets is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Aviglic MF 80 mg/500 mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Aviglic MF 80 mg/500 mg tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Aviglic MF 80 mg/500 mg tablets cautiously, potentially requiring dosage modification. Consult your physician. In those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Aviglic MF 80mg/500mg Tablet :

Should you forget a dose of Aviglic MF 80 mg/500 mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Aviglic MF 80mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Aviglic MF 80mg/500mg Tablet

Aviglic MF 80 mg/500 mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a balanced diet and consistent physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose output and improves insulin responsiveness. This dual-agent therapy is unsuitable for treating type 1 diabetes.
Aviglic MF 80 mg/500 mg Tablets may cause common adverse reactions such as low blood sugar, taste disturbances, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare but potentially severe reactions, including lactic acidosis, are also possible. Prolonged therapy may result in vitamin B12 deficiency.
Indeed, taking Aviglic MF 80 mg/500 mg tablets may lead to hypoglycemia (low blood sugar). This can manifest as nausea, headache, irritability, hunger pangs, sweating, dizziness, a rapid heartbeat, and feelings of anxiety or shakiness. The risk increases if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, consistent blood sugar monitoring is crucial. Having readily available glucose tablets, honey, or fruit juice is recommended.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Aviglic MF 80 mg/500 mg Tablet. Also termed Metformin-associated lactic acidosis (MALA), this complication is uncommon but necessitates immediate medical attention. The risk is heightened in individuals with pre-existing kidney impairment, the elderly, and those who consume substantial alcohol. Symptoms may manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should any of these symptoms appear, discontinue Aviglic MF 80 mg/500 mg Tablet use and seek prompt medical advice.
Indeed, prolonged use of Aviglic MF 80 mg/500 mg tablets can lead to vitamin B12 insufficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency might result in anemia, neurological complications, such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some investigators.
Patients with hypersensitivity to Aviglic MF 80 mg/500 mg Tablet constituents or inactive ingredients should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Aviglic MF 80 mg/500 mg tablets with alcohol is unsafe. This combination can lead to dangerously low blood sugar (hypoglycemia) and a heightened risk of lactic acidosis.
Aviglic MF 80 mg/500 mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when combined with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose output and improves cellular insulin responsiveness. This formulation is unsuitable for individuals with type 1 diabetes.
Aviglic MF 80 mg/500 mg Tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, Aviglic MF 80 mg/500 mg tablets may induce hypoglycemia (low blood glucose). Characteristic symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This adverse effect is amplified by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is strongly recommended.
Aviglic MF 80 mg/500 mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this is an uncommon adverse reaction to metformin. To minimize risk, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, and heavy alcohol consumers. Lactic acidosis symptoms might include muscular aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Aviglic MF 80 mg/500 mg tablet use and seek immediate medical attention.
Prolonged use of Aviglic MF 80 mg/500 mg tablets can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive measures, according to some studies, include supplemental vitamin B12 at least annually.
Patients with hypersensitivity to Aviglic MF 80 mg/500 mg Tablet components or excipients should not use this medication. Similarly, its use is contraindicated in individuals with moderate to severe renal impairment or metabolic acidosis, such as diabetic ketoacidosis.
Combining Aviglic MF 80 mg/500 mg tablets with alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and raises the probability of lactic acidosis.
Aviglic MF 80mg/500mg Tab...
50
MRP 61
18% off